The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Derivation of dose/volume constraints for the anorectum from clinician-reported outcomes (CRO) in the CHHiP trial of radiotherapy (RT) fractionation.
 
Anna Wilkins
No Relationships to Disclose
 
Olivia Frances Naismith
No Relationships to Disclose
 
Douglas Brand
No Relationships to Disclose
 
Katie Fernandez
No Relationships to Disclose
 
Emma Hall
Research Funding - Accuray (Inst); Alliance HealthCare Services (Inst); AstraZeneca (Inst); Aventis Pharma (Inst); Bayer Health (Inst); Kyowa Hakko Kirin (Inst)
 
David P. Dearnaley
Honoraria - Janssen; Sandoz; Takeda
Consulting or Advisory Role - Cadence Research and Consulting; FirstWord; Janssen; Janssen Research & Development; Sandoz; Takeda
Speakers' Bureau - Janssen; Janssen-Cilag
Patents, Royalties, Other Intellectual Property - Abiraterone acetate was developed at The Institute of Cancer Research, which therefore has a commercial interest in the development of this agent. Professor Dearnaley is on the Institute’s Rewards to Inventors list for abiraterone acetate. (Inst)
Expert Testimony - Vitality Life
Travel, Accommodations, Expenses - Janssen; Takeda
 
Sarah Gulliford
No Relationships to Disclose